🇺🇸 FDA
Pipeline program

Semaglutide, 0.5 mg/mL

R87970/RE001

Unknown small_molecule completed

Quick answer

Semaglutide, 0.5 mg/mL for Cognitive Change is a Unknown program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Cognitive Change
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials